Pacira Biosciences, Inc. (PCRX)
21.45
-0.28
(-1.29%)
USD |
NASDAQ |
Feb 12, 16:00
21.47
+0.02
(+0.09%)
After-Hours: 20:00
Pacira Biosciences Market Cap : 922.81M for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.495B |
| CorMedix, Inc. | 579.89M |
| Krystal Biotech, Inc. | 7.837B |
| Arcutis Biotherapeutics, Inc. | 3.272B |
| ADMA Biologics, Inc. | 3.710B |
Market Cap Related Metrics
| PE Ratio | 48.08 |
| PS Ratio | 1.388 |
| Price to Book Value | 1.269 |
| Price to Free Cash Flow | 8.008 |
| Price | 21.45 |
| Earnings Yield | 2.08% |
| Operating PE Ratio | 16.58 |
| Normalized PE Ratio | 28.97 |